SHANGHAI, Oct. 22, 2018 /PRNewswire/ -- Reistone Biopharma Company Limited ( Reistone ), a clinical stage biopharmaceutical company headquartered in Shanghai, today announced the US FDA approval of IND for phase II clinical trial to investigate the effica